Skip to main content
SpringerLink
Log in

Serum free carnitine levels during valproic acid therapy

  • Letter to Editor
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Laub MC, Paetzke-Brunner I, Jaeger G. Seum carnitine during valproic acid therapy.Epilepsia 1982; 27: 559–562.

    Article  Google Scholar 

  2. Beghi E, Bizzi A, Godegoni AMet al. Valporate, carnitine metabolism, and biochemical indicator of liver functionEpilepsia 1990; 31: 346–352.

    Article  CAS  PubMed  Google Scholar 

  3. Bohan TP, Millington DS, Roe CRet al Valproyl carnitine a novel metabolite of valproic acid.Ann Neurol 1980; 16: 394.

    Google Scholar 

  4. Ohtani Y, Endo F, Matsuda J. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.J Pediatr 1982; 101: 782–785.

    Article  CAS  PubMed  Google Scholar 

  5. Opala G, Winter S, Vanceet al. The effect of valproic acid on plasma carnitine levels.Am J Dis Child 1991; 145: 999–1001.

    CAS  PubMed  Google Scholar 

  6. Sakemi K, Hayasaka K, Tahara Met al. The effect of carnitine on the metabolism of valproic acids in epileptic patients.Tohoku J Exp Med 1992; 167: 89–92.

    Article  CAS  PubMed  Google Scholar 

  7. Dreifuss FE, Santilli N, Langer DHet al. Valproic acid hepatic fatalities: A retrospective review.Neurology 1987; 37 : 379–385.

    Article  CAS  PubMed  Google Scholar 

  8. Zimmerman H, Ishak KC. Valproate-induced hepatic injury; Analyses of 23 fatal cases.Hepatology 1982; 2: 591–597.

    Article  CAS  PubMed  Google Scholar 

  9. Sugimoto T. Reye-like syndrome associated with valproic acid.Brain Development 1983; 5: 334–337.

    Article  CAS  PubMed  Google Scholar 

  10. Bratton SL, Gardeb AL, Bohan TP, French JW, Clarke WR. A child with Valproic acid-associated carnitine deficiency and carnitine-responsive cardiac dysfunction.J Child Neurology 1992; 7: 413–416.

    Article  CAS  Google Scholar 

  11. Mathis RK, Lindahl JA, Freese DK, Sharp HL. Valproic acid and hepatocyte failure in childrenPediatr Res 1979; 13: 527.

    Google Scholar 

  12. Tennison MB, Miles MV, Pollock GMet al. Valproate metabolites and hepatoxicity in an epileptic population.Epilepisa 1988; 29: 543–547.

    Article  CAS  Google Scholar 

  13. Riva R, Albani F, Gobbi Get al. Carnitine disposition before and during valproate therapy in patients with epilepsy.Epilepsia 1993; 34:184–187.

    Article  CAS  PubMed  Google Scholar 

  14. Zelnik N, Fridkis I, Gruener N. Reduced carnitine and antiepileptic drugs: cause relationship or co-existence ?Acta Pediatr 1995; 84 : 93–95.

    Article  CAS  Google Scholar 

  15. Winter SC, Vance WH, Zorn EMet al. Carnitine deficiency in Paediatrics: experience at Valley Children’s Hospital, Fresno, California. In :L-Carnitine and Its Role in Medicine : From Function to Therapy R. Ferrari, S. Dimauro, G. Sherwood (Eds). Academic Press Limited, San Diego, New York, Boston, Sydney, Tokyo, Toronto 1992; 209–221.

    Google Scholar 

  16. Melegh B, Kerner J, Acsadi Get al. L-carnitine replacement therapy in chronic valproate treatment.Neuropediatrics 1990; 20:40–43.

    Article  Google Scholar 

  17. Thorn H, Carter PE, Cole GF, Stevenson KL. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugsDev Med and Child Neurol 1991; 33: 795–802.

    Google Scholar 

  18. Coulter DL, Allen RJ. Hyperammonemia with valproic acid therapy.J Pediatr 1981; 99: 317–319.

    Article  CAS  PubMed  Google Scholar 

  19. Costel M, Miguez MP, O’Conner JEet al. Effect of hyperammonemia on the levels of carnitine in mice.Neurology 1987; 37: 804–808.

    Article  Google Scholar 

  20. Riva R, Zaccaro G, Albani Fet al. Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients.Epilepsy Res 1991; 8: 149–152.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Ege Üniversitesi Tip Fakültesi, Çocuk Sagligi ve Hastaliklari Anabilim Dali, Bornova-ÏZMIR, Turkey

    Sarenur Tütüncüoglu, Husan Tekgül, Ertürk Levent & Afig Hüseyinov

Authors
  1. Sarenur Tütüncüoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Husan Tekgül
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ertürk Levent
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Afig Hüseyinov
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tütüncüoglu, S., Tekgül, H., Levent, E. et al. Serum free carnitine levels during valproic acid therapy. Indian J Pediatr 64, 567–571 (1997). https://doi.org/10.1007/BF02737771

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02737771

Keywords

Search

Navigation